Furthermore, analysis of independent validation datasets confirmed that PRKG2 is the most effective gene for distinguishing SSc and LUAD from the normal population, suggesting that PRKG2 is a core gene shared between SSc and lung cancer. This evidence concerns the gene PRKG2 and systemic sclerosis.